Vulnerability Description
A remote code execution vulnerability affecting a Valmet DNA service listening on TCP port 1517, allows an attacker to execute commands with SYSTEM privileges This issue affects: Valmet DNA versions from Collection 2012 until Collection 2021.
CVSS Score
HIGH
Affected Products
| Vendor | Product | Versions |
|---|---|---|
| Valmet | Dna | >= 2012, <= 2021 |
Related Weaknesses (CWE)
References
- https://www.nozominetworks.com/labs/vulnerability-advisories/cve-2021-26726/Third Party Advisory
- https://www.valmet.com/about-us/research-and-development/vulnerabilityadvisoriesVendor Advisory
- https://www.nozominetworks.com/labs/vulnerability-advisories/cve-2021-26726/Third Party Advisory
- https://www.valmet.com/about-us/research-and-development/vulnerabilityadvisoriesVendor Advisory
FAQ
What is CVE-2021-26726?
CVE-2021-26726 is a vulnerability with a CVSS score of 8.8 (HIGH). A remote code execution vulnerability affecting a Valmet DNA service listening on TCP port 1517, allows an attacker to execute commands with SYSTEM privileges This issue affects: Valmet DNA versions f...
How severe is CVE-2021-26726?
CVE-2021-26726 has been rated HIGH with a CVSS base score of 8.8/10. Review the CVSS metrics above for detailed severity breakdown.
Is there a patch for CVE-2021-26726?
Check the references section above for vendor advisories and patch information. Affected products include: Valmet Dna.